INTER PHARMA PUBLIC COMPANY LIMITEDSET: IP🇹🇭 TH

Board Performance · 2025

Compliance Monitoring — Overview

Monitoring of Compliance with Other CG Policies & Guidelines

The Company places great importance on good corporate governance and has established relevant policies and guidelines under its Corporate Governance Policy and Code of Business Conduct. The Company also actively promotes effective implementation of such policies to build confidence among all stakeholder groups.

In 2025, the Company monitored compliance with good corporate governance practices covering the following areas: (1) employee welfare and non-discrimination, (2) prevention of unfair competition, (3) environmental management, occupational health, and workplace safety, (4) information security, and (5) human rights. The monitoring results indicated that the Company has fully implemented the guidelines in all such areas.

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

The Board of Directors has carefully considered conflicts of interest and considered measures to prevent conflicts of interest by assigning the Audit Committee to participate in the consideration and approval of related transactions. In addition, the Company has disclosed details of related party transactions that occurred in the financial statements under the specified accounting standards and has a policy prohibiting directors and executives from using the Company's information, whether directly or indirectly. In this regard, the Company must comply with the Stock Exchange of Thailand's announcements applicable to connected transactions of listed companies or the acquisition and disposition of assets of listed companies, as the case may be. In 2025, the Company had no transactions that may cause conflicts of interest.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

The Company ensures that the use of inside information is conducted in compliance with applicable laws and the principles of good corporate governance. Such requirements are set out in writing in the Company’s Code of Business Conduct to prevent the misuse of information for trading in the Company’s securities, with details as follows:

  1. Directors, executives, executives in accounting or finance or equivalent positions, and employees in departments related to inside information that affects the change in the Company's securities price must not use inside information before disclosing it to the public. Such persons are prohibited to trad the Company's securities by oneself, spouse, or minor children, either directly or indirectly, within 1 month prior to disclosure of quarterly and annual financial statements and at least 24 hours after such disclosure.

  2. Directors, executives, and employees in departments that receive inside information that has not yet been disclosed to the public which may affect the change in the price of the Company's securities or other listed companies related to inside information shall not trade the securities of such companies by themselves, their spouses, minor children, either directly or indirectly until the 24-hour period has elapsed after disclosing the information to the public.

  3. Directors and executives are required to report their holding of securities issued by the Company, which are for themselves, their spouses, and their minor children, to the Securities and Exchange Commission according to relevant requirements, including informing the changes in the holding of such securities to the Board of Directors regularly.

  4. Directors and executives who shall change their holding of securities issued by the Company are required to notify the Company secretary at least 1 day in advance.

  5. Directors and executives shall disclose information about their interests and related persons for the Board of Directors to consider the Company's transactions that may have conflicts of interest and make decisions for the benefit of the Company as a whole. Directors and executives who have stakes in the transactions with the Company shall not participate in decision-making on such transactions. However, this shall be in accordance with the related party transaction approval procedures or measures of the Company.

  6. The Company has informed and educated its Directors, Executives, and Employees about preventing the use of inside information and regular prevention of conflicts of interest and such a policy has been prepared for everyone to know and adhere to.

In this regard, in 2025, there were no instances of trading in the Company’s securities by executive directors, executives in charge of accounting or finance functions or equivalent positions, or employees in units related to inside information during the blackout periods prescribed by the Company.

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

The Company has established a written Anti-Corruption Policy, which requires the Board of Directors, executives, and employees to strictly comply with anti-corruption principles. The Board of Directors has assigned the Audit Committee to oversee the internal control system, while management is responsible for promoting awareness and communicating ethical conduct and integrity in the performance of duties to all employees. The Company has implemented and enforced the Anti-Corruption Policy as follows:

  1. The policy has been communicated to directors, executives, and employees at all levels, with a requirement that all operations be conducted in strict compliance with applicable laws and regulations.

  2. The Company has established whistleblowing channels for reporting any violations of the policy or suspected acts of corruption, together with appropriate measures to protect whistleblowers.

  3. The Board of Directors reviews the Anti-Corruption Policy at least once a year.

  4. The Company monitors compliance with the Anti-Corruption Policy. In 2025, it was found that the policy was fully complied with, and no complaints or reports relating to corruption were received.

  5. The Company plans to participate in the Thai Private Sector Collective Action Against Corruption (CAC) within 2026.

In 2025, the Company did not receive any complaints or whistleblowing reports related to fraud or corruption, and the details of the Company's Anti-Corruption Policy are disclosed on the Company's website at www.interpharma.co.th under the “Investor Relations” section, in the “Corporate Governance” category.

Form of Anti-Corruption Operations

Operation
Review of appropriateness in anti-corruption
The participation in anti-corruption projects
Communication and training for employees on anti-corruption policy and guidelines
The monitoring of the evaluation of compliance with the anti- corruption policy

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

Yes

Operations in the Past Year

The Company provides channels for the stakeholders to report complaints and whistleblowing through the channels provided as follows:

  1. Postal mail, or delivered to:

Chairman of the Board and/or Chairman of the Audit Committee

Inter Pharma Public Company Limited

No. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong Sub-District, Bangrak District, Bangkok 10500

  1. Electronic mail at comsec@interpharma.co.th

  2. The Company’s website at www.interpharma.co.th

The Audit Committee, independent from the management division, will be a reviewer. The Investigation Committee will screen such clues and complaints.

In 2025, the Company did not find any clues and complaints related to corruption and/or violation of the Company's corporate governance policy, and/or unethical business practices, and/or human rights violations.

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Number of Directors from Major Shareholders

2

Rights of Minority Shareholders on Director Appointment

1. The procedure for minority shareholders to nominate candidates for the position of director is to make the nomination through the Company secretary at least 3 months prior to the meeting date, along with information for considering the qualifications and consent of the nominee.

The qualifications of shareholders to nominate a person for consideration as mentioned above are in accordance with Section 89/28 of the Securities and Exchange Act, which requires one or more shareholders holding shares and having voting rights in aggregate of not less than 5% of the total number of voting rights of the Company. The shares must be held continuously from the date of shareholding until the date of proposing such an agenda for not less than 12 months. In addition, shareholders who hold shares until the date of the general meeting of shareholders have the right to nominate a person to be considered for election as a director of the Company.

A person who will be nominated for a director position must have all qualifications in accordance with the Public Company Limited Act, the Securities and Exchange Act, as well as the regulations of the Securities and Exchange Commission, the Capital Market Supervisory Board, the Stock Exchange of Thailand, and the Company's regulations, including other qualifications as specified by the Company. Qualifications of directors include knowledge, competence, expertise, and experience that can benefit and suit the nature of the business of the Company, have good work records, are independent, perform their duties with honesty, morality, and ethics, and be able to regularly attend the Board of Directors Meetings, etc.

Any person to be nominated as a director of the Company will be reviewed by the Nomination and Remuneration Committee and presented to the Board of Directors for consideration and submission to the Shareholders’ Meeting or not. The opinion of the Board of Directors shall be deemed final.

2. Shareholders are given the opportunity to exercise their rights to appoint individual directors. The selection and appointment of directors are in accordance with the method specified in the Company's articles of association. One shareholder has a vote equal to one share per vote, and in the election of directors, the voting method shall be used to select directors individually, and shareholders have the right to elect nominated candidates as directors, not exceeding the number of directors elected at that time. The votes cannot be split, even in the case of the election of several people as directors. The person receiving the highest number of votes in descending order will be elected as a director in an amount equal to the number of directors to be elected at that time. In the event that the candidates in subsequent order have equal votes, which would otherwise exceed the number of directors required or to be elected at that time, the chairman of the meeting shall have a casting vote. The shareholders' meeting must approve the appointed directors. The resolution of the shareholders' meeting is based on the majority vote of the shareholders who attend the meeting and have the right to vote.

In 2025, the Nomination and Remuneration Committee has provided shareholders with an opportunity to participate in proposing qualified directors to be proposed to the 2026 Annual General Meeting of Shareholders during the period from October 1, 2025 to December 31, 2025, it was found that no shareholders proposed any agenda items and names of persons to be considered for election as directors of the Company.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

Regulations for selecting independent directors are based on the regulations for nominating directors of the Board. The qualifications of those who will act as independent directors are considered from the qualifications and prohibited characteristics according to the Public Limited Companies Act, including the Securities and Exchange Act, relevant notifications, rules, and/or regulations. The independent directors shall have educational qualifications, specialized work experience, and other appropriateness to propose to the Shareholders’ Meeting for further consideration and appointment as a director of the Company. If any independent director vacates office before the end of the term, the Board of Directors may appoint an independent director with the abovementioned qualifications to take the position. The replacement of the independent director will be in the office only for the remaining term of the independent director.

The Board of Directors has set the qualifications of independent directors as follows:

1. Holding no more than 1% of the total eligible voting shares of the Company, parent companies, subsidiaries, associated companies, major shareholders, or controlling person of the Company, by totally counting the shares held by related persons to such independent director.

2. Not being a director participating in a management role, an employee, staff, advisor who receives a regular salary, or a controlling person, or the Company, parent companies, subsidiaries, associated companies, same level subsidiaries, major shareholders, or a controlling person of the Company during the past 2 years before his/her appointment as an independent director. Except for the case that he/she was a government official or government advisor who is a major shareholder or controlling person of the Company.

3. Having no relation by blood or by legal registration as the father, mother, spouse, brother or sister, and child, including the spouse of a child of other directors, executives, major shareholders, control person or person who is nominated to be the director, executives, or control person of the Company or subsidiaries.

4. Having no business relation with the Company, parent companies, subsidiaries, associated companies, major shareholder, or controlling person of the Company that would impede his/her independent discretion. Not being or having been a significant shareholder or controlling person of the Company of a business relationship with the Company, parent companies, subsidiaries, associated companies, major shareholder or controlling person of the Company, unless clear from the foregoing relationship for not less than two years.

The term ‘business relationship’ aforementioned under paragraph one includes any normal business transaction, rental or lease of immovable property, transaction relating to assets or services, grant or receipt of financial assistance through receiving or extending loans, guarantee, providing assets as collateral, including any other similar action, which results in the Company or its counterparty being subject indebtedness payable to the other party in the amount of 3 percent or more of the net tangible assets of the company or 20 million Baht or more, whichever is lower. The amount of such indebtedness shall be calculated according to the calculation method for the value of connected transactions under the Notification of the Capital Market Supervisory Board concerning Rules on Connected Transactions mutatis mutandis. The combination of such indebtedness shall include indebtedness taking place during the course of 1 year prior to the date on which the business relationship with the person is commenced.

5. Not be or used to be an auditor of the Company, its parent company, subsidiaries, associated companies, or controlling persons. The person must not be a significant shareholder or controlling person or managing partner of an audit firm that employs auditors of the Company, its parent company, subsidiaries, associated companies, major shareholders, or controlling persons of the Company, unless the foregoing relationship already ended for no less than 2 years prior to the date of appointment.

6. Not being or having been an auditor of the Company, parent companies, subsidiaries, associated companies, major shareholder, or controlling person of the Company. Not being or having been partners of an audit firm, where the auditor of the Company, parent companies, subsidiaries, associated companies, major shareholder, or controlling person of the Company, except for the case of being exempted from having such characteristics, unless clear from those characteristics, for not less than 2 years.

7. Not being a director appointed for the representation of the Company's directors, major shareholders, or shareholders who are related persons of the major shareholders of the Company.

8. Not undertaking any businesses, the nature of which is the same as the Company or its subsidiaries and, in any material respect, is competitive with the business of the Company or its subsidiaries. Not being a substantial partner in the partnership, or a director who is involved in the Company management, an employee, a staff member, an advisor who receives a regular salary, or a shareholder holding more than one percent of shares with voting rights of a company, the nature of whose business is the same as the Company. In any material respect, it is competitive with the business of the Company or its subsidiaries.

9. Not having any characteristics that could prevent giving an independent opinion on the operation of the Company.

The independent directors may be assigned by the Board of Directors to make decisions on the business operations of the Company, its parent company, subsidiaries, associated companies, same-level subsidiaries, major shareholders, or a person with authority from the Company whose decisions can be made in the form of a collective decision.

If the person appointed by the Company to be an independent director is an individual who has or was has a business relationship or provision of professional services over the prescribed value in article (4) or article (6), the Board of Directors may grant a respite if the said individual appointment does not affect the performance of duties and giving independent opinions and the Company has already disclosed the following information in the Shareholders’ Meeting invitation letter on the agenda to consider the appointment of the aforementioned independent directors.

  1. Nature of business relationship or professional service which makes such person qualified, not in accordance with the specified regulations

  2. Reasons and necessity for retaining or appointing the individual as an independent director

  3. Opinions from the Board of Directors in proposing the appointment of the individual as an independent director

In this regard, independent directors shall check and attest their independent qualifications at least once a year, which will be notified together with the director information report at the end of the year for the preparation of the annual registration statement (Form 56-1) and the Company’s annual report.

Did Any Independent Director Have a Business or Professional Relationship?

No

Director Development

Qualifications for Director Selection

QualificationSkill & Expertise
The Nomination and Remuneration Committee, is responsible for selecting and screening qualified individuals in accordance with the Company's regulations. To obtain professional and diverse directors, the structure, size and composition of the board will be considered. The number of directors proposed to be directors will be equal to the number of directors whose terms are due to expire or in other cases. The opinions will be submitted to the Board of Directors for consideration of the persons to be nominated for election and submitted to the shareholders' meeting for consideration and approval. In the election of directors, the Company will allow shareholders to elect directors individually by having all the votes they have cast to elect each nominated director. The Nomination and Remuneration Committee will consider and select qualified persons, possess expertise from various professions, have leadership, broad vision, are moral and ethical, and have a transparent work history, including the ability to express opinions independently, taking into account the following important elements: 1. Personal characteristics of the person who will be selected for nomination as a director in various fields are as follows: 1.1 Integrity and accountability 1.2 Informed judgment 1.3 Be mature and stable, a good listener, and dare to express different and independent opinions. 1.4 Adhere to work with professional principles and standards. 1.5 Other features that the Audit Committee deems important 2. The specific expertises are needed to be on the Board so that the Board can formulate strategies and policies, and supervise the implementation of strategies effectively, for example: 2.1 Health sciences knowledge 2.2 Accounting and finance knowledge 2.3 Organization and human resource management 2.4 Risk management 2.5 Crisis management 2.6 Industry knowledge 2.7 Strategic - domestic and international marketing knowledge 2.8 Strategic planning 2.9 Other specific knowledge and expertise that the Board of Directors deems necessary for the Company's business operations in the next 3 - 5 years, including knowledge related to the Company's business strategies, are health and safety regulations knowledge, research & development, e-commerce knowledge, merger & acquisition, etc. 117 · Description: Personal Products & Pharmaceuticals · 140 · Description: Information & Communication Technology · 164 · Description: Strategic Management · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

The Company conducts an annual performance evaluation of the Board of Directors to enhance the effectiveness of corporate governance and to continuously improve Board performance in line with best practices. The evaluation covers the Board as a whole (Board Evaluation), Board Committees (Committee Evaluation), and individual directors (Individual Evaluation). The assessment criteria include Board structure and composition, roles and responsibilities, strategic direction and oversight, risk management and internal control, compliance with applicable laws and corporate governance principles, as well as meeting effectiveness, independence of views, and active participation of directors.

The Company adopts a self-assessment approach comprising four evaluation forms:

1. Board of Directors self-assessment to evaluate the overall effectiveness of the Board in discharging its duties and responsibilities in overseeing the Company’s operations. The evaluation covers six key areas:

  1. Board structure and composition

  2. Roles, duties, and responsibilities of the Board

  3. Board meeting practices

  4. Directors’ performance

  5. Relationship between the Board and management

  6. Directors’ development

2. Individual Director Self-Assessment is conducted to encourage directors to review their individual performance and to reinforce their awareness of their roles and responsibilities. The evaluation covers five key areas:

  1. Director qualifications

  2. Readiness and commitment to perform duties

  3. Participation in Board meetings

  4. Roles, duties, and responsibilities

  5. Relationship with management

3. Board Committee self-assessment of its sub-committees to review their effectiveness and ensure continuous improvement in their performance. The Company’s sub-committees comprise: Audit Committee, Nomination and Remuneration Committee, Risk Management Committee, Corporate Governance and Sustainability Committee, and Executive Committee. The evaluation framework covers four key areas:

  1. Structure and qualifications of sub-committee members

  2. Meeting practices

  3. Roles, duties, and responsibilities

  4. Reporting to the Board of Directors

4. Chief Executive Officer performance evaluation, which is conducted by independent directors and non-executive directors. The evaluation framework consists of two main sections:

Section 1: Performance Measurement. This section covers ten key aspects, including:

  1. Leadership

  2. Strategy formulation

  3. Strategy execution

  4. Financial planning and performance

  5. Relationship with the Board of Directors

  6. Relationship with external stakeholders

  7. Human resource management

  8. Succession planning

  9. Knowledge of products and services

  10. Personal attributes

Section 2: CEO Development

Each evaluation form applies a scoring system expressed as a percentage of the total score for each criterion, with the following rating scale: 91–100% = Excellent, 81–90% = Very Good, 71–80% = Good, 60–70% = Fair, and below 59% = Needs Improvement. Directors are also encouraged to provide additional comments and recommendations to support the continuous improvement of the Board’s performance.

The evaluation results are reported to the Board of Directors for acknowledgment and are used as a basis for the ongoing enhancement of the Company’s corporate governance effectiveness.

Evaluation of Board Performance in the Past Year

In 2025, the Board of Directors and its sub-committees conducted self-assessments, with the results summarized as follows:

1. Board of Directors (Collective) Evaluation
The evaluation was completed by 9 directors. The overall average score was 96.44%, which is rated as Excellent. The Board considered that its structure is appropriate, directors have a clear understanding of their roles, duties, and responsibilities, and are able to perform their duties collectively in an effective manner to support the Company’s business operations.

2. Individual Director Evaluation
The evaluation was completed by 9 directors, with an average score of 96.75%, rated as Excellent.

3. Board Committee Evaluation

  1. Audit Committee: Evaluated by 3 members, with an average score of 92.29% (Excellent)

  2. Nomination and Remuneration Committee: Evaluated by 3 members, with an average score of 92.53% (Excellent)

  3. Risk Management Committee: Evaluated by 3 members, with an average score of 98.06% (Excellent)

  4. Corporate Governance and Sustainable Development Committee: Evaluated by 4 members, with an average score of 93.79% (Excellent)

  5. Executive Committee: Evaluated by 4 members, with an average score of 88.33% (Very Good)

4. Chief Executive Officer Performance Evaluation
The evaluation was conducted by 6 independent directors and non-executive directors. The average score was 94.63%, rated as Excellent, reflecting that the Chief Executive Officer has performed his duties effectively and in alignment with assigned roles and responsibilities.

Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Board Of DirectorY96.44100Y96.75100N
Audit CommitteeY92.29100NN
Other SubcommitteeY92.53100NN
Other SubcommitteeY98.06100NN
Other SubcommitteeY93.79100NN
Executive CommitteeY88.33100NN

Subcommittees

Subcommittees

Results of the Subcommittee's Duty Performance

The Nomination and Remuneration Committee performed its duties in accordance with the scope of authority and responsibilities as stipulated in the Nomination and Remuneration Committee Charter, based on the principles of transparency, fairness, and appropriateness, in alignment with the Company’s strategy and operating performance. The key performances in 2025 can be summarized as follows:

1. Nomination and Appointment of Directors
The Committee considered and nominated qualified individuals with knowledge, capabilities, experience, and expertise beneficial to the Company’s business operations. Such individuals must also possess qualifications in accordance with applicable laws and relevant regulations. The nominated candidates were then proposed to the Board of Directors for consideration and/or to the shareholders’ meeting for appointment as directors in place of those retiring by rotation.

2. Establishment of Criteria and Consideration of Remuneration for Directors and Subcommittees
The Committee reviewed the remuneration framework to ensure that it was appropriate for the roles, duties, and responsibilities of the directors. Consideration was given to the Company’s performance, business size, and benchmarking against other listed companies within the same industry before proposing the remuneration to the Board of Directors and/or the shareholders’ meeting for approval.

3. Determination of the Chief Executive Officer’s Remuneration
The Committee considered the structure and criteria for determining the remuneration of the Chief Executive Officer, taking into account performance, responsibilities, and the ability to achieve the Company’s strategic objectives, as well as benchmarking with other listed companies in the same industry.

4. Consideration of the Succession Plan
The Committee regularly reviewed the succession plan for senior executives to ensure that the Company has capable and qualified personnel ready to assume key positions, in alignment with the Company’s strategic direction and growth.

5. Performance Evaluation and Self-Assessment
The Committee considered the guidelines and results of the performance evaluation and self-assessment of the Board of Directors, subcommittees, and the Chief Executive Officer. The evaluation results were used as supporting information for determining remuneration and for continuously improving the effectiveness of the Company’s governance and operations.

6. Providing Shareholders the Opportunity to Nominate Director Candidates in Advance
The Committee reviewed the criteria and procedures for allowing shareholders to nominate qualified candidates for election as directors in advance of the Annual General Meeting of Shareholders, in order to promote good corporate governance practices and encourage shareholder participation.

In this regard, the Nomination and Remuneration Committee performed its duties with due care, independence, and in consideration of the best interests of the Company and all stakeholder groups, in order to support good corporate governance and the sustainable long-term growth of the Company.

The Corporate Governance and Sustainability Committee performed its duties in accordance with the scope of authority and responsibilities stipulated in the Corporate Governance and Sustainability Committee Charter. The Committee focuses on promoting good corporate governance alongside sustainable business development across environmental, social, and governance dimensions (Environmental, Social and Governance: ESG) in order to create long-term value for all stakeholder groups. The key performances in 2025 can be summarized as follows:

1. Oversight of Compliance with Good Corporate Governance Principles
The Committee reviewed the Company’s corporate governance policies and practices to ensure alignment with the requirements of regulatory authorities and internationally recognized best practices, while monitoring the effective implementation of such policies across the organization.

2. Promotion of Sustainability Practices (ESG Integration)
The Committee considered approaches to integrate environmental, social, and governance issues into the Company’s corporate strategy, risk management framework, and business operations in order to enhance the Company’s operational standards toward sustainable development.

3. Monitoring Environmental and Social Performance
The Committee monitored the management of resources, initiatives to reduce environmental impacts, responsible supply chain management, as well as social contribution activities and community engagement.

4. Oversight of Business Ethics and Anti-Corruption Practices
The Committee regularly reviewed the Company’s Code of Conduct and anti-corruption policies, while promoting strict compliance among directors, executives, and employees. The Committee also supported the establishment of effective and fair whistleblowing channels.

5. Promotion of Transparency and Information Disclosure
The Committee oversaw the disclosure of accurate, complete, and timely information in compliance with applicable laws and regulatory requirements, in order to strengthen confidence among shareholders and investors.

6. Review of the Charter and Related Policies
The Committee reviewed the Corporate Governance and Sustainability Committee Charter as well as other related key policies to ensure that they remain appropriate, up to date, and consistent with the evolving business environment. Such reviews are conducted at least once a year.

In this regard, the Corporate Governance and Sustainability Committee performed its duties with due care, transparency, and independence, taking into consideration the best interests of the Company and all stakeholder groups, in order to support the Company’s stable and sustainable long-term growth.

The Risk Management Committee performed its duties in accordance with the scope of authority and responsibilities as stipulated in the Risk Management Committee Charter. The Committee focused on overseeing the establishment and maintenance of an effective and comprehensive risk management system that is aligned with the Company’s strategies and business objectives. The key performances in 2025 can be summarized as follows:

1. Establishment and Review of the Risk Management Policy
The Committee reviewed the Company’s risk management policy and framework to ensure their appropriateness in response to the changing business environment, as well as their alignment with the Company’s strategies, business plans, and investment expansion.

2. Oversight of Enterprise Risk Management (ERM)
The Committee monitored the identification, assessment, and prioritization of key risks across the organization, including strategic, financial, operational, legal, corporate governance, information technology, and sustainability risks. Appropriate control measures and risk mitigation plans were also established to manage such risks effectively.

3. Consideration of Significant and Emerging Risks
The Committee monitored risks that may significantly impact the Company’s business operations, such as economic volatility, changes in laws and regulations, supply chain risks, and technology-related risks, in order to ensure preparedness and the timely establishment of appropriate response measures.

4. Monitoring the Effectiveness of Internal Control Measures
The Committee coordinated with management and relevant departments to monitor the implementation of risk management plans and regularly assess the adequacy and effectiveness of the Company’s internal control systems.

5. Reporting Risk Management Results to the Board of Directors
The Committee summarized the results of risk assessments and the status of key risk management activities and reported them to the Board of Directors for acknowledgement and policy recommendations.

6. Promotion of a Risk Management Culture within the Organization
The Committee encouraged executives and employees at all levels to recognize the importance of risk management and to integrate risk management processes into their daily operations.

In this regard, the Risk Management Committee performed its duties with due care, transparency, and independence in providing constructive recommendations to strengthen the Company’s stability and support its long-term sustainable business operations.

Meeting Attendance & Remuneration

Types of Remuneration of the Board of Directors

Remuneration Determination Policy for Directors

The Company has established a policy for determining directors’ remuneration in alignment with its strategy and long-term objectives. The remuneration is determined by taking into consideration directors’ experience, duties, scope of roles, accountability and responsibilities, expected contributions, and the Company’s operating performance in the previous year. It also takes into account business expansion and profitability growth. The remuneration rates are benchmarked against those of comparable companies within the same industry which the Board of Directors has assigned the Nomination and Remuneration Committee to consider the structure and rate of directors' remuneration, both monetary and non-monetary, to be appropriate both remuneration at a fixed rate (such as regular compensation meeting allowance) and remuneration according to the Company's performance (such as bonuses, gratuities) and propose to the Board of Directors meeting for consideration and present to the Shareholders’ Meeting for approval annually.

  1. Monetary remuneration comprises monthly remuneration and meeting allowances.

In 2025, the 2025 Annual General Meeting of Shareholders held on April 28, 2025, approved the monthly remuneration and meeting allowance of the Board of Directors and sub-committees as follows:

Details

Year 2025

Monthly Remuneration (Person: Month)

For non-executive directors

  • Chairman

  • Director

30,000 Baht

20,000 Baht

Meeting Allowances for non-executive directors (Baht: Time)

(Pay only for attendees)

20,000 Baht

15,000 Baht

Board of Director

  • Chairman

  • Director

Audit Committee

  • Chairman of Audit Committee

  • Audit Committee

22,500 Baht

15,000 Baht

Nomination and Remuneration Committee

  • Chairman

  • Director

15,000 Baht

10,000 Baht

Corporate Governance and Sustainable Development Committee

  • Chairman

  • Director

15,000 Baht

10,000 Baht

Risk Management Committee

  • Chairman

  • Director

15,000 Baht

10,000 Baht

However, the directors who are executives and employees of the Company shall not receive monthly remuneration and meeting allowances for the positions of the Company's directors above because they already got the remuneration from the Company in the form of salary as employees of the Company.

The Company has a policy to pay bonuses to independent directors and non-executive directors (collectively) of not more than 0.5% of the total dividend declared. The Board of Directors and/or persons authorized by the Board are responsible for allocating such bonuses among the independent directors and non-executive directors.

  1. Other remuneration: None

In this regard, the aggregate of monthly remuneration, meeting allowances, directors’ bonuses, and other benefits in any form payable to the Board of Directors shall not exceed THB 4,000,000 per annum.

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Does the Company Have Subsidiaries or Associated Companies?

Yes

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

1. The Company has the policy to invest in businesses that are related to the core business of the Company and that have the potential to generate profits and have growth opportunities to increase the Company's profitability or be beneficial businesses (synergy) to the Company by realizing the return that will be received from the investment through controlling and supervising the management of the subsidiary as if it were a unit of the Company. Also, it shall monitor the management to maintain the benefits of the Company's investments continuously and sustainably, create added value, and build confidence among the Company's stakeholders. Accordingly, the Company has established policies for the control and supervision of its subsidiaries and associates in which the Company has invested, by defining management structures for such subsidiaries and associates to oversee management and assume responsibility for the operations of the subsidiaries and associates as follows:

Nomination of Individuals to be Directors and Executives of the Subsidiaries and Associated Companies

1.1 The Company will send individuals approved by the Board of Directors Meeting to be directors and executives in the subsidiaries and associated companies to supervise and establish the management policy as a part of the Company. The number of people who will join as directors in the subsidiaries are mainly based on the Company's shareholding in the subsidiaries or in accordance with an agreement. For investments in the associated companies, the Company needs the policy to control more. Submission of representatives to join as directors of the associated companies will be appropriately considered, depending on the agreement. Such individuals must have appropriate qualifications and experience in managing the business of such subsidiaries and associated companies.

1.2 Scope of Duties and Responsibilities of Directors and Executives in Subsidiaries and Associated Companies

  • Follow up the operations of the subsidiaries and associated companies closely to achieve the goals set by the Company.

  • Perform duties as assigned by the Board of Directors of the subsidiaries and associated companies and/or the Shareholders’ Meeting of the subsidiaries or associated companies.

  • Consider and vote at the Board of Director Meeting of the subsidiaries and associated companies in general operations of the subsidiaries and associated companies as the directors and executives of the subsidiaries and associated companies seem appropriate for the utmost benefit of the subsidiaries, associated companies, and the Company, except for consideration and voting on the following, which must be approved by the Board of Directors and/or the Company's Shareholders’ Meeting depending on the case before proceeding.

(1) Transactions of the subsidiaries are in accordance with the notification of connected transactions and the notification of acquisition[1]and disposition[2].

(2) Transactions which may have a significant impact on the finance and the subsidiaries’ operations are listed below:

- Sell or transfer all or some significant portions of the subsidiaries to other people.

- Purchase or accept the business transfer of other companies to be in the possession of the subsidiaries.

- Dissolve the subsidiaries.

- Transfer or waive significant benefits and claims that can cause damages to the subsidiaries.

- Borrow money, lend, guarantee, encumber, or provide financial assistance to other companies that significantly affect the subsidiaries’ finances.

- Revise the articles of association of the subsidiaries.

- Capital increase, share allocation, and the reduction of the registered capital of the subsidiaries, as well as other actions that directly and indirectly cause the Company's shareholding to decrease from 10 % of the paid-up capital of the subsidiary to holding less than 50 % of the paid-up capital of that subsidiary.

3. Directors and executives of the subsidiaries, including the related individual of such directors and executives, are responsible for reporting to the Board of Directors of the subsidiaries about the relationships and transactions with subsidiaries in ways that may cause conflicts of interest and shall avoid entering into any transactions that may cause conflicts of interest with such subsidiaries. In this regard, the Board of Directors of the subsidiaries is responsible for reporting such matters to the Company.

Directors and executives of the subsidiaries must not participate in approving matters in which they have interests or conflicts of interest.

4. Subsidiaries are required to report business plans, investment projects, and joint ventures with other operators to the Company through the subsidiaries' monthly performance report, including providing information or documents related to operations upon request. In the event that the Company detects any significant issues, it may notify the subsidiary to clarify and/or submit documents for consideration by the Company.

5. The Company has assigned financial control policies for subsidiaries and associated companies. The subsidiaries and associated companies have the duties as follows:

  • Submit monthly results and quarterly reviewed financial statements reviewed by a certified public accountant as well as supporting information for the preparation of such financial statements of subsidiaries and associated companies for the Company to support the preparation of the consolidated financial statements or report the Company's quarterly or annual performance, depending on circumstances.

  • Prepare overall operation estimates and summarize the comparison of the planned operation with the actual operation on a quarterly basis, including following up on the performance to be in accordance with the plan that has been set for reporting to the Company.

  • Report significant financial issues to the Company when they are discovered or be requested by the Company to carry out an investigation and report.


[1] Related Listing Announcement means the Securities and Exchange Commission's announcement No. 21/2008 regarding the criteria for related transactions and the Stock Exchange of Thailand's announcement regarding the disclosure of information and the operation of registered companies involved in related listings in 2003 and subsequent amendments.

[2] The Listing Announcement and Distribution means the Securities and Exchange Commission's announcement No. 20/2008 regarding significant criteria for acquired or disposed assets and the Stock Exchange of Thailand's announcement regarding the disclosure of information and the operation of registered companies involved in acquired or disposed assets in 2004 and subsequent amendments.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies
Disclosure of financial information and operating results
Transactions between the Company and related persons
Other important transactions
Acquisition or disposal of assets
Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business

Board Duty Performance — Overview

Board Duty Performance — Overall Description

The Board of Directors has performed its duties within the scope of authority assigned with responsibility, due care, and integrity, for the best interests of the Company and all stakeholders. The Board has focused on ensuring that the Company’s operations are conducted in accordance with the principles of good corporate governance, while also monitoring and determining the direction of the Company’s business operations to ensure alignment with its strategies and objectives.

The Board of Directors places importance on establishing the Company’s policies, strategies, and operational plans, as well as closely monitoring the performance of the management team to ensure that the Company’s operations are efficient, transparent, and capable of generating sustainable growth. In addition, the Board has considered and approved significant corporate matters, including risk management, oversight of the internal control system, and compliance with applicable laws, regulations, and relevant requirements.

In terms of corporate governance, the Board of Directors has promoted operations in accordance with good governance principles, emphasizing transparency, accountability, and responsibility toward all stakeholder groups. The Board also supports business development alongside social and environmental responsibility.

In this regard, in 2025 the Company adopted the principles of good corporate governance as the Company’s operational guidelines.

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

In 2025, the Audit Committee performed its duties in accordance with the scope of authority and responsibilities stipulated in the Audit Committee Charter, as well as the requirements of the Stock Exchange of Thailand. The Committee carried out its duties independently, with due care, prudence, and integrity, while taking into consideration the best interests of the Company, its shareholders, and all stakeholders. In this regard, the Audit Committee supervised and monitored the Company’s operations in key areas as summarized below:

1. Oversight of the Internal Audit Function and Internal Control System
The Audit Committee oversaw the performance of the internal audit function by reviewing and approving the annual internal audit plan, monitoring the results of internal audits, and following up on corrective actions taken in response to the internal auditor’s recommendations. The Committee also reviewed the adequacy and effectiveness of the Company’s internal control system to ensure that the Company has an appropriate and effective internal control framework consistent with the nature of its business operations and capable of properly managing significant risks.

2. Oversight of the Company’s Financial Reporting
The Audit Committee reviewed the quarterly and annual financial statements of the Company and its subsidiaries together with the management and the external auditor. The Committee also inquired with management regarding key matters related to the preparation of financial reports, including the use of accounting judgments, the selection of significant accounting policies, and the adequacy of disclosures in the financial statements. This review was conducted to ensure that the Company’s financial statements were prepared accurately and completely in accordance with applicable financial reporting standards, with sufficient, transparent, and reliable disclosures, prior to submission to the Board of Directors for approval.

3. Communication of Significant Matters between the Audit Committee and the External Auditor
The Audit Committee held regular meetings with the external auditor to acknowledge the audit plan, the results of the financial statement audit, and significant issues identified during the audit, including observations and recommendations from the auditor. In addition, the Audit Committee provided the external auditor with the opportunity to discuss matters with the Committee without the presence of management, in order to ensure that the external auditor could perform duties independently and communicate important audit-related matters openly and transparently.

4. Consideration of the Independence of the External Auditor and Non-Audit Services
The Audit Committee considered the independence of the external auditor, including the provision of non-audit services. The Committee reviewed the nature and scope of such services to ensure that they did not create conflicts of interest or impair the independence of the external auditor in performing the audit of the Company’s financial statements. The Audit Committee concluded that the provision of such services did not affect the independence of the external auditor.

5. Other Duties within the Scope of the Audit Committee
The Audit Committee also performed other duties as stipulated in the Audit Committee Charter, including reviewing the Company’s compliance with applicable laws, regulations, and relevant requirements; considering transactions that may involve conflicts of interest; and reviewing related-party transactions to ensure that such transactions are reasonable, transparent, and conducted in the best interests of the Company and its shareholders as a whole.

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

The Executive Committee of the Company has performed its duties within the scope of authority delegated by the Board of Directors, with emphasis on supervising and monitoring operations to ensure alignment with the Company’s strategic plans, objectives, and approved budgets, in order to achieve stable and sustainable growth. The key performance highlights for 2025 are summarized as follows:

1. Formulation and Execution of Corporate Strategy
Reviewed and refined the Company’s strategic plan and annual business plan to ensure alignment with the prevailing economic conditions, industry landscape, and competitive environment. Established corporate goals and key performance indicators (KPIs) to achieve the Company’s objectives.

2. Supervision and Monitoring of Operating Performance
Regularly monitored financial and operational performance against the approved budget and targets. Analyzed key influencing factors and implemented appropriate corrective and improvement measures where necessary.

3. Management of Investments and Key Projects
Considered and screened investment projects, business expansions, and strategic partnerships prior to proposing them to the Board of Directors for approval, taking into account expected returns, associated risks, and alignment with the Company’s strategic direction.

4. Oversight of Risk Management and Internal Control
Ensured the implementation of an appropriate risk management framework and internal control system, and supported relevant units in effectively addressing issues identified through audits and reviews.

5. Human Resource Management and Organizational Development
Promoted the development of executives and employees, succession planning, and the cultivation of a corporate culture that fosters efficiency, transparency, and accountability.

6. Compliance with Laws and Regulations
Oversaw the Company’s compliance with applicable laws, regulations, and regulatory requirements, while promoting adherence to good corporate governance principles.

The Executive Committee has carried out its duties with due care, transparency, and adherence to good governance principles, taking into account the best interests of the Company and all stakeholders to support sustainable long-term growth.

Contents